Oral contraceptives use and weight gain in women with a Central European life-style

European Journal of Contraception and Reproductive Health Care

Volumn 10, Issue 1, 2005, Pages 59-65

  Lech, Medard M ^a   Ostrowska, L ^b  

^a Fertility and Sterility Research Center   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Family planning; Observational study; Oral contraceptives; Weight gain

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DELIVERY; DRUG USE; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OBESITY; ORAL CONTRACEPTION; POLAND; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; RANDOMIZATION; RETROSPECTIVE STUDY; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; EUROPE; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; LOGISTIC MODELS; MIDDLE AGED; OBESITY; POLAND; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WEIGHT GAIN;

EID: 20344363881     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180500039084     Document Type: Article

References (20)

1. Cybulska K, Kłoś J. Antykoncepcja doustna a choroby układu krżenia u kobiet. Kardiol Pol 2000;52(Suppl.3): 61-5
2. Lech M, Światek E. Practices of prescribing oral contraceptives in Poland. Eur J Contracept Reprod Health Care 2001;6:27-33
3. Wysocki S. A survey of American women regarding the use of oral contraceptives and weight gain (abstract). Int J Gynecol Obstet 2000;70(Suppl 1):114
4. Hatcher RA, Rinehart W, Blackburn R, et al. The Essentials of Contraceptive Technology. Baltimore: Population Information Council, The Johns Hopkins University, 2001:54-5
5. Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control and side effects of low- and lower-dose oral contraceptives: a randomized trail of 20 μg, and 35 μg estrogen preparations. Contraception 2000;60:321-9
6. Eck LH, Bennett AG, Egan BM, et al. Differences in macronutrient selections in users and nonusers of an oral contraceptive. Am J Clin Nutr 1997;65:419-24
7. Kamiński K, Wojdan R. Antykoncepcja z zastosowaniem nowej generacji niskodawkowych preparatów antykoncepcyjnych zawierajcych 20 lub 30 μg EE i 150 μg DSG-korzyści i ryzyko. Gin Prakt 2001;9(61):8-21
8. PonJola C, Washenik K, Langley RGB, et al. Weight change and adverse event incidence with low-dose oral contraceptive: two randomized, placebo controlled trials. Contraception 2001;63:297-302
9. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995;51: 283-8
10. Aubeny E, Buhler M, Colau JC, et al. Oral contraception: patterns of non-compliance. The Coraliance study. Eur J Contracept Reprod Health Care 2002;7:155-61
11. Goldzieher JW, Moses LE, Averkin E, et al. A placebo controlled double-blind crossover investigation of the side effects attributed to oral contracrptives. Fertil Steril 1971;22:609-23
12. Redmond G, Godwin AJ, Olson W, Lippman J. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception 2000;60:81-5
13. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Contraception 1998;58:345-9
14. Pelkman CL, Heinbach RA, Rolls BJ. Reproductive hormones and eating behavior in young women. Appetite 2000;34:217-18
15. Ball K, Brown W, Crawford D. Who does not gain weight? Prevalence and predictors of weight maintenance in young women. Int J Obes 2002;26:1570-8
16. Ryan AS, Pratley RE, Elahi D. Resistive training increases fat-free mass and maintain RMR despite weight loss in postmenopausal women. Appl Physiol 1995;79:818-23
17. Hassan DF, Petta CA, Aldrighi JM, et al. Weight variation in a cohort of women using cooper IUD for contraception. Contraception 2003;68:27-30
18. Lech MM, Ostrowska L. Effects of low-dose OCs on weight in women with Central European nutritional habits and lifestyle. Contraception 2002;66:159-62
19. Lloyd T, Hung Molin, Mathews AE, et al. Oral contraceptive use not associated with weight gain. Obstet Gynecol 2002;100:235-9
20. Endrikat J, Gerlinger C, Cronin M, et al. Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake. Eur J Contracept Reprod Health Care 2001;6:199-204